A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

Joseph Zohar; Stephen Stahl; Hans Jurgen Moller; Pierre Blier; David Kupfer; Shigeto Yamawaki; Hiroyuki Uchida; Michael Spedding; Guy M. Goodwin; David Nutt

doi:10.1016/j.euroneuro.2015.08.019

A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

Joseph Zohar, Stephen Stahl, Hans Jurgen Moller, Pierre Blier, David Kupfer, Shigeto Yamawaki, Hiroyuki Uchida, Michael Spedding, Guy M. Goodwin, David Nutt

Department of Psychiatry

Research output: Contribution to journal › Article › peer-review

115 Citations (Scopus)

Abstract

Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.

Original language	English
Pages (from-to)	2318-2325
Number of pages	8
Journal	European Neuropsychopharmacology
Volume	25
Issue number	12
DOIs	https://doi.org/10.1016/j.euroneuro.2015.08.019
Publication status	Published - 2015 Dec 1

Keywords

Adherence
Mode of action
Neuroscience
Nomenclature
Pharmacological domain
Psychotropic drugs

ASJC Scopus subject areas

Pharmacology
Neurology
Clinical Neurology
Psychiatry and Mental health
Biological Psychiatry
Pharmacology (medical)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.euroneuro.2015.08.019

Cite this

@article{d713102f95d94c14bf27270d387e4f2b,

title = "A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature",

abstract = "Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.",

keywords = "Adherence, Mode of action, Neuroscience, Nomenclature, Pharmacological domain, Psychotropic drugs",

author = "Joseph Zohar and Stephen Stahl and Moller, {Hans Jurgen} and Pierre Blier and David Kupfer and Shigeto Yamawaki and Hiroyuki Uchida and Michael Spedding and Goodwin, {Guy M.} and David Nutt",

note = "Funding Information: This project was funded by the ECNP (Neutoscience-based-Nomenclature) . Publisher Copyright: {\textcopyright} 2015.",

year = "2015",

month = dec,

day = "1",

doi = "10.1016/j.euroneuro.2015.08.019",

language = "English",

volume = "25",

pages = "2318--2325",

journal = "European Neuropsychopharmacology",

issn = "0924-977X",

publisher = "Elsevier",

number = "12",

}

TY - JOUR

T1 - A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

AU - Zohar, Joseph

AU - Stahl, Stephen

AU - Moller, Hans Jurgen

AU - Blier, Pierre

AU - Kupfer, David

AU - Yamawaki, Shigeto

AU - Uchida, Hiroyuki

AU - Spedding, Michael

AU - Goodwin, Guy M.

AU - Nutt, David

PY - 2015/12/1

Y1 - 2015/12/1

N2 - Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.

AB - Neuroscience based Nomenclature (NbN) is a new system of classifying psychotropic drugs by their pharmacological profile. The NbN was developed to replace the current indication-based nomenclature and to provide an up-to-date and more useful framework to better inform pharmacological decisions. NbN provides updated relevant and specific scientific, regulatory and clinical information, aiming to support rational and lucid prescribing. This pharmacologically driven nomenclature, which highlights pharmacological domains and modes of action, may also increase drug adherence as it clarifies the rationale for selecting a specific psychotropic agent.

KW - Adherence

KW - Mode of action

KW - Neuroscience

KW - Nomenclature

KW - Pharmacological domain

KW - Psychotropic drugs

UR - http://www.scopus.com/inward/record.url?scp=84959851997&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84959851997&partnerID=8YFLogxK

U2 - 10.1016/j.euroneuro.2015.08.019

DO - 10.1016/j.euroneuro.2015.08.019

M3 - Article

C2 - 26527055

AN - SCOPUS:84959851997

SN - 0924-977X

VL - 25

SP - 2318

EP - 2325

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

IS - 12

ER -

A review of the current nomenclature for psychotropic agents and an introduction to the Neuroscience-based Nomenclature

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this